Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1985 1
1986 1
1987 1
1988 2
1989 2
1990 5
1991 9
1992 7
1993 5
1994 6
1995 4
1996 11
1997 11
1998 16
1999 14
2000 14
2001 16
2002 26
2003 28
2004 47
2005 66
2006 74
2007 74
2008 79
2009 72
2010 96
2011 104
2012 150
2013 187
2014 209
2015 286
2016 257
2017 306
2018 410
2019 483
2020 559
2021 624
2022 774
2023 796
2024 727
2025 1

Text availability

Article attribute

Article type

Publication date

Search Results

5,845 results

Results by year

Filters applied: . Clear all
Page 1
Multi-omics blood atlas reveals unique features of immune and platelet responses to SARS-CoV-2 Omicron breakthrough infection.
Wang H, Liu C, Xie X, Niu M, Wang Y, Cheng X, Zhang B, Zhang D, Liu M, Sun R, Ma Y, Ma S, Wang H, Zhu G, Lu Y, Huang B, Su P, Chen X, Zhao J, Wang H, Shen L, Fu L, Huang Q, Yang Y, Wang H, Wu C, Ge W, Chen C, Huo Q, Wang Q, Wang Y, Geng L, Xie Y, Xie Y, Liu L, Qi J, Chen H, Wu J, Jiang E, Jiang W, Wang X, Shen Z, Guo T, Zhou J, Zhu P, Cheng T. Wang H, et al. Among authors: guo t. Immunity. 2023 Jun 13;56(6):1410-1428.e8. doi: 10.1016/j.immuni.2023.05.007. Epub 2023 May 16. Immunity. 2023. PMID: 37257450 Free PMC article.
Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilities.
Jiang YZ, Ma D, Jin X, Xiao Y, Yu Y, Shi J, Zhou YF, Fu T, Lin CJ, Dai LJ, Liu CL, Zhao S, Su GH, Hou W, Liu Y, Chen Q, Yang J, Zhang N, Zhang WJ, Liu W, Ge W, Yang WT, You C, Gu Y, Kaklamani V, Bertucci F, Verschraegen C, Daemen A, Shah NM, Wang T, Guo T, Shi L, Perou CM, Zheng Y, Huang W, Shao ZM. Jiang YZ, et al. Among authors: guo t. Nat Cancer. 2024 Apr;5(4):673-690. doi: 10.1038/s43018-024-00725-0. Epub 2024 Feb 12. Nat Cancer. 2024. PMID: 38347143
An immunometabolism subtyping system identifies S100A9+ macrophage as an immune therapeutic target in colorectal cancer based on multiomics analysis.
Bao X, Wang D, Dai X, Liu C, Zhang H, Jin Y, Tong Z, Li B, Tong C, Xin S, Li X, Wang Y, Liu L, Zhu X, Fu Q, Zheng Y, Deng J, Tian W, Guo T, Zhao P, Chen W, Fang W. Bao X, et al. Among authors: guo t. Cell Rep Med. 2023 Apr 18;4(4):100987. doi: 10.1016/j.xcrm.2023.100987. Epub 2023 Mar 28. Cell Rep Med. 2023. PMID: 36990096 Free PMC article.
Population serum proteomics uncovers a prognostic protein classifier for metabolic syndrome.
Cai X, Xue Z, Zeng FF, Tang J, Yue L, Wang B, Ge W, Xie Y, Miao Z, Gou W, Fu Y, Li S, Gao J, Shuai M, Zhang K, Xu F, Tian Y, Xiang N, Zhou Y, Shan PF, Zhu Y, Chen YM, Zheng JS, Guo T. Cai X, et al. Among authors: guo t. Cell Rep Med. 2023 Sep 19;4(9):101172. doi: 10.1016/j.xcrm.2023.101172. Epub 2023 Aug 30. Cell Rep Med. 2023. PMID: 37652016 Free PMC article.
Cellular and molecular imaging of CAR-T cell-based immunotherapy.
Liu L, Yoon CW, Yuan Z, Guo T, Qu Y, He P, Yu X, Zhu Z, Limsakul P, Wang Y. Liu L, et al. Among authors: guo t. Adv Drug Deliv Rev. 2023 Dec;203:115135. doi: 10.1016/j.addr.2023.115135. Epub 2023 Nov 4. Adv Drug Deliv Rev. 2023. PMID: 37931847 Review.
5,845 results